2021.V2 美国国家癌症综合网络临床实践指南:胰腺癌更新解读

2022-01-20 哈尔滨医科大学附属第一医院胰胆外科/肝脾外科教育部重点实验室 临床外科杂志

胰腺癌转移能力强,复发率高,预后差,早期诊断困难,是恶性程度最高的肿瘤之一。根治性手术切除是胰腺癌主要治疗方式,但病人长期生存率并未随手术技术发展而提高。随着国内外循证医学证据更新,众多学者认识到胰腺

中文标题:

2021.V2 美国国家癌症综合网络临床实践指南:胰腺癌更新解读

发布日期:

2022-01-20

简要介绍:

胰腺癌转移能力强,复发率高,预后差,早期诊断困难,是恶性程度最高的肿瘤之一。根治性手术切除是胰腺癌主要治疗方式,但病人长期生存率并未随手术技术发展而提高。随着国内外循证医学证据更新,众多学者认识到胰腺癌不仅是局部性疾病,更是一种系统性疾病,病人无法单纯通过手术切除改善预后、延长生存期,需在多学科协作诊疗模式(multidisciplinary team, MDT)指导下进行系统性治疗。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021.V2 NCCN临床实践指南:胰腺癌更新解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7dc4b1c002386619, title=2021.V2 美国国家癌症综合网络临床实践指南:胰腺癌更新解读, enTitle=, guiderFrom=临床外科杂志, authorId=0, author=, summary=胰腺癌转移能力强,复发率高,预后差,早期诊断困难,是恶性程度最高的肿瘤之一。根治性手术切除是胰腺癌主要治疗方式,但病人长期生存率并未随手术技术发展而提高。随着国内外循证医学证据更新,众多学者认识到胰腺, cover=https://img.medsci.cn/2022319/1647669757083_5579292.png, journalId=0, articlesId=null, associationId=2535, associationName=哈尔滨医科大学附属第一医院胰胆外科/肝脾外科教育部重点实验室, associationIntro=哈尔滨医科大学附属第一医院胰胆外科/肝脾外科教育部重点实验室, copyright=0, guiderPublishedTime=Thu Jan 20 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">胰腺癌转移能力强,复发率高,预后差,早期诊断困难,是恶性程度最高的肿瘤之一。根治性手术切除是胰腺癌主要治疗方式,但病人长期生存率并未随手术技术发展而提高。随着国内外循证医学证据更新,众多学者认识到胰腺癌不仅是局部性疾病,更是一种系统性疾病,病人无法单纯通过手术切除改善预后、延长生存期,需在多学科协作诊疗模式(multidisciplinary team, MDT)指导下进行系统性治疗。</span></p>, tagList=[TagDto(tagId=718, tagName=胰腺癌), TagDto(tagId=25496, tagName=胰腺疾病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5135, appHits=172, showAppHits=0, pcHits=324, showPcHits=4963, likes=1, shares=30, comments=5, approvalStatus=1, publishedTime=Sat Mar 19 15:43:00 CST 2022, publishedTimeString=2022-01-20, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Mar 19 14:02:55 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 10:49:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021.V2 NCCN临床实践指南:胰腺癌更新解读.pdf)])
2021.V2 NCCN临床实践指南:胰腺癌更新解读.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1212097, encodeId=908a121209eeb, content=2021.V2是最新版吗,哪里可以下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af462045116, createdName=1841ea91c6m, createdTime=Mon Apr 18 09:04:05 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206309, encodeId=2fb0120630935, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Sun Mar 27 11:06:23 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204308, encodeId=ff8712043082b, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74d96561621, createdName=ms2000000983422947, createdTime=Sun Mar 20 10:59:47 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204246, encodeId=77fe12042462e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/33ad203afd5c4425b1c37e6bc0063ce0/de81a0bd89774bf692d2dafcf2d19b80.jpg, createdBy=32ab6393736, createdName=msXu, createdTime=Sun Mar 20 08:51:10 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-04-18 1841ea91c6m

    2021.V2是最新版吗,哪里可以下载

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1212097, encodeId=908a121209eeb, content=2021.V2是最新版吗,哪里可以下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af462045116, createdName=1841ea91c6m, createdTime=Mon Apr 18 09:04:05 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206309, encodeId=2fb0120630935, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Sun Mar 27 11:06:23 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204308, encodeId=ff8712043082b, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74d96561621, createdName=ms2000000983422947, createdTime=Sun Mar 20 10:59:47 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204246, encodeId=77fe12042462e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/33ad203afd5c4425b1c37e6bc0063ce0/de81a0bd89774bf692d2dafcf2d19b80.jpg, createdBy=32ab6393736, createdName=msXu, createdTime=Sun Mar 20 08:51:10 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-03-27

    值得一看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1212097, encodeId=908a121209eeb, content=2021.V2是最新版吗,哪里可以下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af462045116, createdName=1841ea91c6m, createdTime=Mon Apr 18 09:04:05 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206309, encodeId=2fb0120630935, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Sun Mar 27 11:06:23 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204308, encodeId=ff8712043082b, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74d96561621, createdName=ms2000000983422947, createdTime=Sun Mar 20 10:59:47 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204246, encodeId=77fe12042462e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/33ad203afd5c4425b1c37e6bc0063ce0/de81a0bd89774bf692d2dafcf2d19b80.jpg, createdBy=32ab6393736, createdName=msXu, createdTime=Sun Mar 20 08:51:10 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-03-20 ms2000000983422947

    值得一看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1212097, encodeId=908a121209eeb, content=2021.V2是最新版吗,哪里可以下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af462045116, createdName=1841ea91c6m, createdTime=Mon Apr 18 09:04:05 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206309, encodeId=2fb0120630935, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Sun Mar 27 11:06:23 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204308, encodeId=ff8712043082b, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74d96561621, createdName=ms2000000983422947, createdTime=Sun Mar 20 10:59:47 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204246, encodeId=77fe12042462e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/33ad203afd5c4425b1c37e6bc0063ce0/de81a0bd89774bf692d2dafcf2d19b80.jpg, createdBy=32ab6393736, createdName=msXu, createdTime=Sun Mar 20 08:51:10 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-03-20 msXu

    不错

    0